BackAkoya Biosciences Overview

Akoya Biosciences Receivables

Akoya Biosciences's receivables is $12M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$11.74M
12.85% YoYΔ $-1.73M vs prior year quarter

Peer average

Loading

Akoya Biosciences Receivables History

Loading

Akoya Biosciences vs. peers: Receivables Comparison

Loading

Akoya Biosciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Akoya Biosciences (AKYA) FAQ

As of the most recent data (March 2025), AKYA shows a receivables of $12M. That compares with $13M in the prior-year period — down 12.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AKYA's receivables is now $12M (was $13M) — a 12.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Akoya Biosciences is outperforming or lagging.

Tracking AKYA's receivables over time shows whether Akoya Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $12M That compares with $13M in the prior-year period — down 12.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Akoya Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $12M) with ownership activity and broader fundamentals.

Akoya Biosciences's receivables is $12M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.